Transforming Protein Myb (AA 119-135) anticorps
Aperçu rapide pour Transforming Protein Myb (AA 119-135) anticorps (ABIN6294290)
Antigène
Reactivité
Hôte
Clonalité
Application
-
-
Épitope
- AA 119-135
-
Fonction
- Mouse anti-Human c-Myb Antibody [Sodium Azide Free]
-
Specificité
- Nuclear
-
Purification
- Amino acids 119-135 (RRKVEQEGYPQESSKAG) from the human protein were used as the immunogen for this c-Myb antibody.
-
Immunogène
- Amino acids 119-135 (RRKVEQEGYPQESSKAG) from the human protein were used as the immunogen for this c-Myb antibody.
-
-
-
Indications d'application
-
Flow Cytometry: 0.5-1 μg/million cells in 0.1ml
Immunofluorescence: 1-2 μg/mL -
Restrictions
- For Research Use only
-
-
-
Buffer
- In 1X PBS, BSA free, sodium azide free
-
Agent conservateur
- Azide free
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- 2-8°C. The azide-free format should be aliquoted and stored at -20°C or colder.
-
-
- Transforming Protein Myb
-
Sujet
-
Target Description: The highly leukemogenic avian retrovirus E26 contains two oncogenes, v-Myb and v-Ets, which are expressed together as a fusion protein. The cellular homolog of v-Myb, designated c-Myb, encodes a transcription factor. Deletion or disruption of a negative regulatory domain mapping within the carboxy-terminal domain of c-Myb results in enhanced transactivating capacity and in parallel, leads to activation of its ability to transform hemopoietic cells. c-Myb is expressed preferentially, but not exclusively, in immature hemopoietic cells and its expression decreases as cells differentiate.
Gene Symbol: V-MYB
-
UniProt
- P01104
Antigène
-